Position in ILMN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$246
-$16 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ALBION FINANCIAL GROUP /UT holds $13,117,631 across 9 Diagnostics & Research names. ILMN ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,328 | $11,957,941 | |
| 2 | A |
Agilent Technologies, Inc.
|
7,826 | $892,007 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $244,584 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
26 | $14,609 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $4,467 | |
| 6 | DGX |
Quest Diagnostics Inc
|
11 | $2,155 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6 | $1,600 | |
| 8 | ILMN |
Illumina, Inc.
This page
|
2 | $246 |
All Filings in ILMN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $246 | 2 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $262 | 2 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $189 | 2 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $190 | 2 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $158 | 2 | Shares | Sole | 2025-04-25 | |
| 2022-06-30 | $538 | 3 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,379 | 7 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,220 | 6 | Shares | Sole | 2022-02-15 | |
| 2020-12-31 | $19,075 | 53 | Shares | Sole | 2021-02-19 | |
| 2020-06-30 | $249,301 | 692 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $203,511 | 766 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||